To provide a method of treatment and/or prevention of cardiovascular disease, rheumatoid arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport enhancement.
The method for preventing and/or treating the diseases includes the administration of a therapeutically effective amount of krill oil and/or marine organism oil to a patient. The composition for preventing and/or treating the diseases is provided. The extracted oil is a free fatty acid lipid fraction derived from krill and/or marine organism living in a marine environment anywhere in the world such as Antarctic Ocean (Antarctic krill (Euphausia superba)), Pacific Ocean (feeler pear krill (Euphausia pacifica)), Atlantic Ocean, Indian Ocean (especially Mauritius island and/or coast domain in La Reunion in Madagascar), Canada West Coast, Japanese coast, Gulf of St. Lawrence, Bay of Fundy, etc.
JP3905267 | INHIBITOR OF INTERLEUKIN 4 PRODUCTION |
JP2002187874 | NEW DIQUATERNARY AMMONIUM COMPOUND |
JPH10152414 | COMPOSITION FOR ROUGH (LIP STICK) |
JPS54119017A | 1979-09-14 | |||
JPH1099053A | 1998-04-21 | |||
JPH08219A | 1996-01-09 | |||
JPH03123470A | 1991-05-27 | |||
JPH01137952A | 1989-05-30 | |||
JPS61118318A | 1986-06-05 | |||
JPH1017475A | 1998-01-20 | |||
JPH0856613A | 1996-03-05 |
WO2000023546A1 | 2000-04-27 |
JPN6012036010; CONNOR,S.L. et al: 'Are fish oils beneficial in the prevention and treatment of coronary artery disease?' Am J Clin Nutr Vol.66, No.4 Suppl, 1997, p.1020S-1031S